RRML - The positive rate of IgM and IgG antibodies against SARS-CoV-2 is similar in severe and non-severe COVID-19 patients
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2019): 0.945

Rejection rate (2020): 75%

Română English


Clarivate analytics (ISI) Impact factor


Advanced search


Top 10 downloaded articles
- February 2021 -
 
The Role of MiR-124 in Bladder... 19
Difficult to treat Proteeae st... 11
The positive rate of IgM and I... 11
FLT3-ITD DNA allelic burden, b... 9
Evaluation of Plasma AA/DHA+EP... 8
Rapid loss of HBs antigen in p... 8
Antibacterial and antitumor ac... 7
Assessment on the influence of... 7
Extended panel of biomarkers f... 7
The role of qSOFA score and bi... 7

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 29(1)/2021 DOI:10.2478/rrlm-2021-0010
XML
TXT

Short communication

The positive rate of IgM and IgG antibodies against SARS-CoV-2 is similar in severe and non-severe COVID-19 patients

Nan Jiang, Yaoyao Sun, Hongyan Sun, Bo Yang, Juan Tan, Huan Sun, Shuai Wang, Qiong Yu

Correspondence should be addressed to: Qiong Yu

Abstract:

Background: Coronavirus disease 2019 (COVID-19) has spread rapidly in China and globally. In order to control the spread of the epidemic, it is important to find an efficient diagnostic method. Objectives: The aim of this study was to assess the responses of antibodies during SARS-CoV-2 infection in relation to disease severity and to evaluate the association between the positive rate of antibody detection and nucleic acid test. Methods: Ninety patients with SARS-CoV-2 infection were recruited in this retrospective observational study. Demographic, clinical data, and SARS-CoV-2 IgM and IgG antibodies in serum specimens were detected at 4 and 6 weeks after diagnosis. Results: IgM and IgG antibody levels showed a decreased tendency, the titers at week 4 were higher than the titers at week 6: The positive rates of IgM at week 4 and 6 were 92.9% and 67.9%, respectively. The positive rates of IgG at week 4 and week 6 were 100%. No association was found between the positive rate of antibody detection at week 4 or 6 and that of nucleic acid test (P>0.05). No difference between the positive rate of antibodies against SARS-CoV-2 in severe and non-severe COVID-19 patients was observed. Conclusions: Antibody detection is an effective means in the diagnosis of COVID-19. The titer and positive rate of IgM are lower than those of IgG in the first six weeks after infection. Positive rate of antibodies was not different between severe and non-severe patients.

Keywords: COVID-19, SARS-CoV-2, Serological test

Received: 1.10.2020
Accepted: 4.1.2021
Published: 15.1.2021

 
  PDF Download full text PDF
(430 KB)
     
 
How to cite
Jiang N, Sun Y, Sun H, Yang B, Tan J, Sun H, et al. The positive rate of IgM and IgG antibodies against SARS-CoV-2 is similar in severe and non-severe COVID-19 patients . Rev Romana Med Lab. 2021;29(1):85-91. DOI:10.2478/rrlm-2021-0010